Vimarsana
Biggest News Aggregation in the World

Page 38 - Tender Offer Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tender Offer Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tender Offer Statement Today - Breaking & Trending Today

iQIYI, Inc. Announces Repurchase Right Notification for 3.75% Convertible Senior Notes due 2023 - Vimarsana News

iQIYI, Inc. Announces Repurchase Right Notification for 3.75% Convertible Senior Notes due 2023

/PRNewswire/ -- iQIYI, Inc. (Nasdaq: IQ) ("iQIYI" or the "Company"), an innovative market-leading online entertainment service in China, today announced that...

MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals - Vimarsana News

MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals

MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals ACCESSWIRE 17 Jun 2021, 08:31 GMT+10 PLANEGG, GERMANY / ACCESSWIRE / June 16, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) ('MorphoSys') today announced that it is commencing a cash tender offer to purchase all outstanding shares of Constellation Pharmaceuticals, Inc., (CNST) ('Constellation') for $34.00 per share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes. The tender offer is being made pursuant to the previously announced merger agreement, date...

MorphoSys : Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals - Vimarsana News

MorphoSys : Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals

MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals MorphoSys AG (FSE: MOR; NASDAQ: MOR) ("MorphoSys") today announced that it is commencing a cash tender offer to purchase all outstanding shares of Constellation Pharmaceuticals, Inc., (NASDAQ: CNST) ("Constellation") for $34.00 per share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes. The tender offer is being made pursuant to the previously announced merger agreement, dated June 2, 2021 between MorphoSys and Constellation....

Thoma Bravo Commences Tender Offer for All Outstanding Shares and ADSs of Talend - Vimarsana News

Thoma Bravo Commences Tender Offer for All Outstanding Shares and ADSs of Talend

/PRNewswire/ -- Thoma Bravo and Talend (NASDAQ: TLND) ("Talend or "the Company") today announced that Thoma Bravo has commenced the previously-announced tender...

Iconix Enters into Definitive Agreement to be Acquired in - Vimarsana News

Iconix Enters into Definitive Agreement to be Acquired in

NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- Iconix Brand Group, Inc. (NASDAQ:ICON) ("Iconix" or the "Company") today announced it has entered into a ...